文献速递神经核医学

PET在脑小血管病评估中的附加价值

The Additional Value of PET in the Assessment of Cerebral Small Vessel Disease.
PubMed 文献 · J Nucl Med · 2018-06-29

脑小血管病(SVD)临床诊断缺乏共识标准,影像学对诊断至关重要;CT可检出缺血性卒中、出血和脑萎缩,MRI因敏感性和特异性更高而优于CT用于血管性认知障碍(VCI)。CT和MRI仅能显示形态学病变,PET可通过可视化典型受累脑区的脑功能支持临床诊断,其中18F-FDG PET能清晰区分散在的局灶性皮质和皮质下代谢减低区,与阿尔茨海默痴呆(AD)的典型代谢模式不同。

要点

  • 脑小血管病诊断缺乏共识临床标准,影像学对诊断重要。
  • MRI是VCI关键神经影像方法,检测病理改变敏感性特异性高于CT。
  • CT和MRI仅显示形态学病变,不能确定病理改变的功能后果。

核心结论

  • PET可通过可视化典型受累脑区的脑功能支持脑小血管病的临床诊断。
  • 18F-FDG PET能清晰区分脑小血管病中散在的局灶性皮质和皮质下代谢减低区,与阿尔茨海默痴呆中累及联络区的显著代谢减低模式不同。
  • 其他PET示踪剂可进一步支持某类痴呆的诊断,并提供潜在病理生理信息。

研究设计与样本

  • 原文为叙述性综述,未报告系统检索范围、纳入研究数量或样本量。

主要发现

  • CT可检出缺血性卒中、出血和脑萎缩,并可提示白质改变。
  • MRI对检测病理改变有更高敏感性和特异性,是VCI首选的神经影像方法。
  • 形态学影像可检出传统上归因于VCI的皮质下血管病变、丘脑或角回等关键部位的单发梗死或腔隙灶,以及达到组织丢失临界阈值的大皮质-皮质下病变。
  • SVD在MRI上可见白质多发点状或融合性病变,称为脑白质疏松;微出血是VCI中SVD的另一主要神经影像表现。
  • 18F-FDG PET可区分SVD散在的局灶性皮质和皮质下代谢减低区与阿尔茨海默痴呆的典型代谢模式。

关键数值与推荐

  • 原文为综述,未汇总具体诊断标准或数值阈值。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The diagnosis of cerebral small vessel disease (SVD) is difficult because there is no consensus on clinical criteria, and therefore imaging is important for diagnosis. Most patients undergo brain imaging by CT, which is able to detect ischemic strokes, hemorrhages, and brain atrophy and may also indicate white matter changes. MRI remains the key neuroimaging modality and is preferred to CT in vascular cognitive impairment (VCI) because it has higher sensitivity and specificity for detecting pathologic changes. These modalities for imaging morphology permit detection of vascular lesions traditionally attributed to VCI in subcortical areas of the brain, single infarction or lacunes in strategic areas (thalamus or angular gyrus), or large cortical-subcortical lesions reaching a critical threshold of tissue loss. In SVD, multiple punctuate or confluent lesions can be seen in the white matter by MRI and were called leukoaraiosis. Another major neuroimaging finding of SVD in VCI are microhemorrhages. However, whereas CT and MRI are able to detect morphologic lesions, these modalities cannot determine functional consequences of the underlying pathologic changes. PET can support the clinical diagnosis by visualizing cerebral functions in typically affected brain regions. In SVD, 18F-FDG PET can clearly differentiate scattered areas of focal cortical and subcortical hypometabolism that differ from the typical metabolic pattern seen in Alzheimer dementia (AD) with marked hypometabolism affecting the association areas. Additional PET tracers can further support the diagnosis of a type of dementia and also yield information on the underlying pathophysiology.

来源:J Nucl Med,查看原文。版权归原作者所有。

引用

  1. Heiss WD. The Additional Value of PET in the Assessment of Cerebral Small Vessel Disease. J Nucl Med. 2018. PMID: 29959217. doi:10.2967/jnumed.118.214270

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。